Watson Pharmaceuticals: Announcement on the company\'s drugs passing the GMP compliance inspection
Watson Pharmaceuticals: Investor Relations Activity Record Form for November 13, 2024
Watson Pharmaceuticals: Investor Relations Activity Record Form for November 11, 2024
Watson Pharmaceuticals: 2024 Third Quarter Results Online Briefing Investor Relations Activity Record Form
Watson Pharmaceuticals: Announcement of Board Resolutions
Watson Pharmaceuticals: Announcement on the company\'s receipt of government subsidies
Watson Pharmaceuticals: 2024 Semi-Annual Results Online Briefing Investor Relations Activity Record Form
Chongqing Pharscin Pharmaceutical: Regulations on information disclosure (August 2024)
Chongqing Pharscin Pharmaceutical: Announcement of the resolution of the Supervisory Board on the semi-annual report.
Chongqing Pharscin Pharmaceutical: Announcement of Board of Directors' resolution for semi-annual report.
Chongqing Pharscin Pharmaceutical: Investor Relations Activity Record Form on July 24th, 2024
Chongqing Pharscin Pharmaceutical: Announcement regarding the company's pharmaceutical production license change and passing the GMP compliance inspection.
Chongqing Pharscin Pharmaceutical: Investor Relations Activity Record Form for June 18, 2024
Chongqing Pharscin Pharmaceutical: Announcement regarding obtaining pharmaceutical registration certificate.
Chongqing Pharscin Pharmaceutical: May 23, 2024 Investor Relations Activity Record
Chongqing Pharscin Pharmaceutical: Announcement of Resolutions of the 12th Meeting of the Third Board of Directors
Chongqing Pharscin Pharmaceutical: 2023 and 2024 First Quarter Results Online Briefing Investor Relations Activity Record Form
Chongqing Pharscin Pharmaceutical: Notice on changes in accounting policies
Watson Pharmaceuticals: Announcement of Board Resolutions
Watson Pharmaceuticals: Announcement on Renewal of the 2024 Accounting Firm
No Data
No Data